Insmed (INSM) Misses Q1 EPS by 7c, Beats on Revenue
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $103.38 --0%
Revenue Growth %: +264.2%
Financial Fact:
Net loss: -37.76M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: +264.2%
Financial Fact:
Net loss: -37.76M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($1.42), $0.07 worse than the analyst estimate of ($1.35). Revenue for the quarter came in at $92.82 million versus the consensus estimate of $90.78 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades Cytokinetics (CYTK) to Buy
- Wolfe Research Starts Frontview REIT Inc (FVR) at Outperform
- TD Cowen Upgrades PBF Energy (PBF) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
